Skip to main content
Log in

Management of the Neck in the Setting of Definitive Chemoradiation: Is There a Consensus? A GETTEC Study

  • Head and Neck Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The management of the neck remains controversial in the definitive chemoradiation setting of advanced N2–3 head and neck squamous cell carcinoma. Most published data favor omission of neck dissection (ND) after complete response for N2–3 or selective ND for residual disease

Methods

We studied the patterns of care in the French-Belgian Groupe d’Etude des Tumeurs de la Tête Et du Cou (GETTEC) through a questionnaire-based survey.

Results

Eighteen percent of institutions never performed up-front ND, 20% rarely, 40% sometimes, 14% often, and 8% systematically. Induction chemotherapy was indicated in 30% of the cases, and most ND were performed either between induction and radiation or after chemoradiation for residual disease. Response to chemoradiation was assessed by computed tomographic scan and positron emission tomography in 72% of cases. Selective ND was more common than radical ND.

Conclusions

Omission of ND based on computed tomographic scan and positron emission tomography–based complete response to chemoradiation is the most common strategy for advanced nodal disease among centers. However, neck management strategies vary among institutions, and some institutions continue advocating systematic ND before irradiation. The new treatment options and the changing epidemiology, namely docetaxel-based induction chemotherapy and human papilloma virus–related head and neck squamous cell carcinoma having better response profiles and prognosis, are adding to the nonconsensual approach. The best therapeutic index in terms of neck management remains to be defined in this evolving context.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ensley JF, Jacobs JR, Weaver A, et al. Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer. 1984;54:811–4.

    Article  PubMed  CAS  Google Scholar 

  2. Peters LJ, Weber RS, Morrison WH, Byers RM, Garden AS, Goepfert H. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck. 1996;18:552–9.

    Article  PubMed  CAS  Google Scholar 

  3. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338:1798–804.

    Article  PubMed  CAS  Google Scholar 

  4. Vedrine PO, Thariat J, Hitier M, et al.; French Groupe d’Etude des Tumeurs de la Tête et du Cou Group. Need for neck dissection after radiochemotherapy? A study of the French GETTEC Group. Laryngoscope. 2008;118:1775–80.

    Article  PubMed  Google Scholar 

  5. Liauw SL, Mancuso AA, Amdur RJ, et al. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol. 2006;24:1421–7.

    Article  PubMed  Google Scholar 

  6. Thariat J, et al. Prediction of neck dissection requirement after definitive radiotherapy for head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 2012;82(3):e367–74.

    Article  PubMed  Google Scholar 

  7. Brizel DM, Prosnitz RG, Hunter S, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;58:1418–23.

    Article  PubMed  Google Scholar 

  8. Prades JM, Timoshenko AP, Schmitt TH, et al. Planned neck dissection before combined chemoradiation for pyriform sinus carcinoma. Acta Otolaryngol. 2008;128:324–8.

    Article  PubMed  CAS  Google Scholar 

  9. Thariat J, Marcy PY. Neck dissection and chemoradiation in head and neck cancer. Lancet Oncol. 2010;11:224–5.

    Article  PubMed  Google Scholar 

  10. Shoushtari A, Meeneghan M, Sheng K, et al. Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status. Cancer. 2010;116:2645–54.

    Article  PubMed  Google Scholar 

  11. Kies MS, Holsinger FC, Lee JJ, et al. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol. 2010;28:8–14.

    Article  PubMed  CAS  Google Scholar 

  12. Yao M, Smith RB, Hoffman HT, et al. Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report. Int J Radiat Oncol Biol Phys. 2009;74:9–14.

    Article  PubMed  CAS  Google Scholar 

  13. Wee JT, Anderson BO, Corry J, et al.; Asian Oncology Summit. Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009;10:1086–92.

    Article  PubMed  Google Scholar 

  14. Malone J, Robbins KT. Neck dissection after chemoradiation for carcinoma of the upper aerodigestive tract: indications and complications. Curr Opin Otolaryngol Head Neck Surg. 2010;18:89–94.

    Article  PubMed  Google Scholar 

  15. Ferlito A, Corry J, Silver CE, Shaha AR, Thomas Robbins K, Rinaldo A. Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence. Head Neck. 2010;32:253–61.

    PubMed  Google Scholar 

  16. Thariat J, Hamoir M, Janot F, et al. [Neck dissection following chemoradiation for node positive head and neck carcinomas]. Cancer Radiother. 2009;13:758–70.

    Article  PubMed  CAS  Google Scholar 

  17. Hamoir M, Ferlito A, Schmitz S, et al. The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease. Oral Oncol. 2011. doi:10.1016/j.oraloncology.2011.10.015.

  18. van der Putten L, van den Broek GB, de Bree R, et al. Effectiveness of salvage selective and modified radical neck dissection for regional pathologic lymphadenopathy after chemoradiation. Head Neck. 2009;31:593–603.

    Article  PubMed  Google Scholar 

  19. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26:3582–9.

    Article  PubMed  CAS  Google Scholar 

  20. Lango MN, Egleston B, Ende K, et al. Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation. Head Neck. 2010;32:341–7.

    PubMed  Google Scholar 

  21. McHam SA, Adelstein DJ, Rybicki LA, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck. 2003;25:791–8.

    Article  PubMed  Google Scholar 

  22. Lango MN, Andrews GA, Ahmad S, et al. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis. Head Neck. 2009;31:328–37.

    Article  PubMed  Google Scholar 

  23. Narayan K, Crane CH, Kleid S, Hughes PG, Peters LJ. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all? Head Neck. 1999;21:606–13.

    Article  PubMed  CAS  Google Scholar 

  24. Stenson KM, Huo D, Blair E, et al. Planned post-chemoradiation neck dissection: significance of radiation dose. Laryngoscope. 2006;116:33–6.

    Article  PubMed  Google Scholar 

  25. Newman JP, Terris DJ, Pinto HA, Fee WE Jr, Goode RL, Goffinet DR. Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer. Ann Otol Rhinol Laryngol. 1997;106:117–22.

    PubMed  CAS  Google Scholar 

  26. Lavertu P, Adelstein DJ, Saxton JP, et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck. 1997;19:559–66.

    Article  PubMed  CAS  Google Scholar 

  27. Goguen LA, Chapuy CI, Li Y, Zhao SD, Annino DJ. Neck dissection after chemoradiotherapy: timing and complications. Arch Otolaryngol Head Neck Surg. 2010;136:1071–7.

    Article  PubMed  Google Scholar 

  28. Yao M, Hoffman HT, Chang K, et al. Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy? Int J Radiat Oncol Biol Phys. 2007;68:707–13.

    Article  PubMed  Google Scholar 

  29. Jones AS, Tandon S, Helliwell TR, Husband DJ, Jones TM. Survival of patients with neck recurrence following radical neck dissection: utility of a second neck dissection? Head Neck. 2008;30:1514–22.

    Article  PubMed  Google Scholar 

  30. Duprez F, Bonte K, De Neve W, Boterberg T, De Gersem W, Madani I. Regional relapse after intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 79:450–8.

  31. Sabatini PR, Ducic Y. Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer. Otolaryngol Head Neck Surg. 2009;141:474–7.

    Article  PubMed  Google Scholar 

  32. Gourin CG, Boyce BJ, Williams HT, Herdman AV, Bilodeau PA, Coleman TA. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer. Laryngoscope. 2009;119:2150–5.

    Article  PubMed  Google Scholar 

  33. Nouraei SA, Upile T, Al-Yaghchi C, et al. Role of planned postchemoradiotherapy selective neck dissection in the multimodality management of head and neck cancer. Laryngoscope. 2008;118:797–803.

    Article  PubMed  Google Scholar 

  34. Mukhija V, Gupta S, Jacobson AS, Eloy JA, Genden EM. Selective neck dissection following adjuvant therapy for advanced head and neck cancer. Head Neck. 2009;31:183–8.

    Article  PubMed  Google Scholar 

  35. Ganly I, Bocker J, Carlson DL, et al. Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcome. Head Neck. 2011;33:1387–93.

    Article  PubMed  Google Scholar 

  36. Clavel S, Charron MP, Bélair M, et al. The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2012;82:567–73.

    Article  PubMed  Google Scholar 

  37. Bremke M, Barth PJ, Sesterhenn AM, Budach V, Engenhart-Cabillic R, Werner JA. Prospective study on neck dissection after primary chemoradiation therapy in stage IV pharyngeal cancer. Anticancer Res. 2009;29:2645–53.

    PubMed  CAS  Google Scholar 

  38. Simon C, Goepfert H, Rosenthal DI, et al. Presence of malignant tumor cells in persistent neck disease after radiotherapy for advanced squamous cell carcinoma of the oropharynx is associated with poor survival. Eur Arch Otorhinolaryngol. 2006;263:313–8.

    Article  PubMed  Google Scholar 

  39. Clayman GL, Johnson CJ 2nd, Morrison W, Ginsberg L, Lippman SM. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg. 2001;127:135–9.

    PubMed  CAS  Google Scholar 

  40. Cannady SB, Lee WT, Scharpf J, et al. Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma. Head Neck. 2010;32:348–56.

    PubMed  Google Scholar 

  41. Koch WM, Ridge JA, Forastiere A, Manola J. Comparison of clinical and pathological staging in head and neck squamous cell carcinoma: results from Intergroup Study ECOG 4393/RTOG 9614. Arch Otolaryngol Head Neck Surg. 2009;135:851–8.

    Article  PubMed  Google Scholar 

  42. Robbins KT, Doweck I, Samant S, Vieira F. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation. Arch Otolaryngol Head Neck Surg. 2005;131:965–9.

    Article  PubMed  Google Scholar 

  43. Ahlberg A, Lagerlund M, Lewin F, Friesland S, Lundgren J. Clinical outcome following radiotherapy and planned neck dissection in N + head and neck cancer patients. Acta Otolaryngol. 2008;128:1–7.

    Article  Google Scholar 

  44. Byers RM, Clayman GL, Guillamondequi OM, Peters LJ, Goepfert H. Resection of advanced cervical metastasis prior to definitive radiotherapy for primary squamous carcinomas of the upper aerodigestive tract. Head Neck. 1992;14:133–8.

    Article  PubMed  CAS  Google Scholar 

  45. Hillel AT, Fakhry C, Pai SI, et al. Selective versus comprehensive neck dissection after chemoradiation for advanced oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2009;141:737–42.

    Article  PubMed  Google Scholar 

  46. Dhiwakar M, Robbins KT, Vieira F, Rao K, Malone J. Selective neck dissection as an early salvage intervention for clinically persistent nodal disease following chemoradiation. Head Neck. 2012;34:188–93.

    Article  PubMed  Google Scholar 

  47. Hamoir M, Leemans CR, Dolivet G, Schmitz S, Grégoire V, Andry G. Selective neck dissection in the management of the neck after (chemo)radiotherapy for advanced head and neck cancer. Proposal for a classification update. Head Neck. 2010;32:816–9.

    PubMed  Google Scholar 

  48. Rogers JW, Greven KM, McGuirt WF, et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys. 2004;58:694–7.

    Article  PubMed  Google Scholar 

  49. Argiris A, Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck. 2004;26:447–55.

    Article  PubMed  Google Scholar 

  50. Corry J, Peters L, Fisher R, et al. N2–N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders—results of Trans Tasman Radiation Oncology Group Study 98.02. Head Neck. 2008;30:737–42.

    Article  PubMed  Google Scholar 

  51. Waldron JN, et al. Results of an Ontario Clinical Oncology Group (OCOG) prospective cohort study on the use of FDG PET/CT to predict the need for neck dissection following radiation therapy of head and neck cancer (HNC) (abstract). J Clin Oncol. 2011;29:5504.

    Google Scholar 

  52. Nayak JV, Walvekar RR, Andrade RS, et al. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT. Laryngoscope. 2007;117:2129–34.

    Article  PubMed  Google Scholar 

  53. Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck. 2005;27:175–81.

    Article  PubMed  Google Scholar 

  54. Yao M, Graham MM, Hoffman HT, et al. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2004;59:1001–10.

    Article  PubMed  Google Scholar 

  55. Schöder H, Fury M, Lee N, Kraus D. PET monitoring of therapy response in head and neck squamous cell carcinoma. J Nucl Med. 2009;50(Suppl 1):74S–88S.

    Article  PubMed  Google Scholar 

  56. Lyford-Pike S, Ha PK, Jacene HA, Saunders JR, Tufano RP. Limitations of PET/CT in determining need for neck dissection after primary chemoradiation for advanced head and neck squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec. 2009;71:251–6.

    Article  PubMed  CAS  Google Scholar 

  57. Rengan R, Pfister DG, Lee NY, et al. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer. Am J Clin Oncol. 2008;31:465–9.

    Article  PubMed  Google Scholar 

  58. Grimard L, Esche B, Lamothe A, Cygler J, Spaans J. Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies. Head Neck. 2006;28:888–95.

    Article  PubMed  Google Scholar 

  59. Goldenberg D, Begum S, Westra WH, et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck. 2008;30:898–903.

    Article  PubMed  Google Scholar 

  60. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261–9.

    Article  PubMed  CAS  Google Scholar 

  61. Marandas P, Germain MA, Casiraghi O, et al. [Cervical cystic lymph-node metastases from epidermoid carcinoma]. Bull Acad Natl Med. 2003;187:1117–27.

    PubMed  Google Scholar 

  62. Haerle SK, Strobel K, Ahmad N, Soltermann A, Schmid DT, Stoeckli SJ. Contrast-enhanced (18) F-FDG-PET/CT for the assessment of necrotic lymph node metastases. Head Neck. 2011;33:324–9.

    PubMed  Google Scholar 

  63. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.

    Article  PubMed  CAS  Google Scholar 

  64. Shonka DC Jr, Shoushtari AN, Thomas CY, et al. Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy: utility of p16 status. Arch Otolaryngol Head Neck Surg. 2009;135:1126–32.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

All GETTEC members participated in the questionnaire, have no financial disclosure, and agree for copyright transfer

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Juliette Thariat MD.

Additional information

This study was conducted on behalf of the Groupe d’Etude des Tumeurs de la Tete Et du Cou (GETTEC).

Appendix

Appendix

Groupe d’Etude des Tumeurs de la Tete Et du Cou

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thariat, J., Hamoir, M., Garrel, R. et al. Management of the Neck in the Setting of Definitive Chemoradiation: Is There a Consensus? A GETTEC Study. Ann Surg Oncol 19, 2311–2319 (2012). https://doi.org/10.1245/s10434-012-2275-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-012-2275-9

Keywords

Navigation